CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guizhou Xinbang Pharmaceutical Company Limited Company Snapshot
Guizhou Xinbang Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Xinbang Pharmaceutical Company Limited with three other companies in this sector in China: Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2018 sales of 6.36 billion Chinese Renmimbi [US$900.25 million] of which 66% was Chinese Medicine), Zhejiang Conba Pharmaceutical Co., Ltd. (6.78 billion Chinese Renmimbi [US$960.62 million] of which 98% was Manufacturing), and FUREN Group Pharmaceutical Co Ltd (6.32 billion Chinese Renmimbi [US$894.41 million] of which 80% was Pharmaceutical Industry).

Sales Analysis. During the year ended December of 2018, sales at Guizhou Xinbang Pharmaceutical Company Limited were 6.58 billion Chinese Renmimbi (US$931.64 million). This is an increase of 9.6% versus 2017, when the company's sales were 6.00 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Guizhou Xinbang Pharmaceutical Company Limited (and since 2013, sales have increased a total of 1,056%). Sales of Medical Services saw an increase of 16.3% in 2018, from 1.34 billion Chinese Renmimbi to 1.56 billion Chinese Renmimbi. Not all segments of Guizhou Xinbang Pharmaceutical Company Limited experienced an increase in sales in 2018: sales of Medicinal Manufacturing fell 10.7% to 775.07 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guizhou Xinbang Pharmaceutical Company Limited
  Stock Performance Chart for Guizhou Xinbang Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (8/23/2019): 5.51
(Figures in Chinese Renmimbi)
1 Week 1.5%   13 Weeks -5.2%  
4 Weeks 1.7%   52 Weeks -5.5%  
 
Guizhou Xinbang Pharmaceutical Company Limited Key Data:
  Ticker: 002390 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 6,580,278,918
(Year Ending Jan 2019).
Employees: 6,994
  Currency: Chinese Renmimbi Market Cap: 9,186,429,647
  Fiscal Yr Ends: December Shares Outstanding: 1,667,228,611
  Share Type: A Gu Closely Held Shares: 960,663,519
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.